设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
CNKI学位论文(1)
知网期刊论文(1)
在“
Elsevier电子期刊
”中,
命中:
5
条,耗时:0.0529744 秒
在所有数据库中总计命中:
2
条
1.
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial
作者:
Dr Jeffrey A Cohen
;
MD
a
;
cohenj@ccf.org" class="auth_mail" title="E-mail the corresponding author
;
Douglas L Arnold
;
MD
b
;
Giancarlo Comi
;
MD
c
;
Amit Bar-Or
;
MD
d
;
Sheila Gujrathi
;
MD
e
;
Jeffrey P Hartung
;
PhD
e
;
Matt Cravets
;
MA
e
;
Allan Olson
;
MD
e
;
Paul A Frohna
;
MD
e
;
Krzysztof
W
Selmaj
;
MD
f
;
for the RADIANCE Study Group
&dagger
;
刊名:Lancet Neurology
出版年:2016
2.
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial
作者:
Prof
Gavin Giovannoni
;
PhD
a
;
g.giovannoni@qmul.ac.uk" class="auth_mail
;
Prof
Ralf Gold
;
MD
b
;
Prof
Krzysztof
Selmaj
;
MD
c
;
Prof
Eva Havrdova
;
MD
d
;
Prof
Xavier Montalban
;
MD
e
;
Prof
Ernst-Wilhelm Radue
;
MD
f
;
Dusan Stefoski
;
MD
g
;
Manjit McNeill
;
MSc
h
;
Lakshmi Amaravadi
;
PhD
h
;
Marianne Sweetser
;
MD
h
;
Jacob Elkins
;
MD
h
;
Gilmore O'Neill
;
MRCPI
h
;
for the SELECTION Study Investigators &dagger
刊名:Lancet Neurology
出版年:May, 2014
3.
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
作者:
Prof
Jeffrey A Cohen
;
MD
a
;
&dagger
;
;
cohenj@ccf.org
;
Alasdair J Coles
;
PhD
c
;
&dagger
;
;
Prof
Douglas L Arnold
;
MD
d
;
Prof
Christian Confavreux
;
MD
e
;
Edward J Fox
;
MD
f
;
Prof
Hans-Peter Hartung
;
FRCP
g
;
Prof
Eva Havrdova
;
MD
h
;
Prof
Krzysztof
W
Selmaj
;
MD
i
;
Prof
Howard L Weiner
;
MD
j
;
Elizabeth Fisher
;
PhD
b
;
Vesna V Brinar
;
MD
k
;
Prof
Gavin Giovannoni
;
PhD
l
;
Miroslav Stojanovic
;
MD
m
;
Bella I Ertik
;
MD
n
;
Stephen L Lake
;
ScD
n
;
David H Margolin
;
MD
n
;
Michael A Panzara
;
MD
n
;
Prof
D Alastair S Compston
;
FRCP
c
;
for the CARE-MS I investigators
&Dagger
;
刊名:The Lancet
出版年:2012
4.
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
作者:
Dr Alasdair J Coles
;
FRCP
a
;
ajc1020@medschl.cam.ac.uk
;
Cary L Twyman
;
MD
e
;
Prof
Douglas L Arnold
;
MD
b
;
Prof
Jeffrey A Cohen
;
MD
c
;
Prof
Christian Confavreux
;
MD
f
;
Edward J Fox
;
MD
g
;
Prof
Hans-Peter Hartung
;
FRCP
h
;
Prof
Eva Havrdova
;
MD
i
;
Prof
Krzysztof
W
Selmaj
;
MD
j
;
Prof
Howard L Weiner
;
MD
k
;
Tamara Miller
;
MD
l
;
Elizabeth Fisher
;
PhD
d
;
Rupert Sandbrink
;
MD
h
;
m
;
Stephen L Lake
;
ScD
n
;
David H Margolin
;
MD
n
;
Pedro Oyuela
;
MD
n
;
Michael A Panzara
;
MD
n
;
Prof
D Alastair S Compston
;
FRCP
a
;
for the CARE-MS II investigators
&dagger
;
刊名:The Lancet
出版年:2012
5.
Microarray gene expression
prof
iling of chronic active and inactive lesions in multiple sclerosis
作者:
Mycko
;
Marcin P.
;
Papoian
;
Ruben
;
Boschert
;
Ursula
;
Raine
;
Cedric S.
;
Selmaj
;
Krzysztof
W.
关键词:
MS
;
multiple sclerosis
;
CNS
;
central nervous system
;
DGE
;
differential gene expression
;
H&E
;
hematoxilin & eosin
;
NAWM
;
normal appearing white matter
;
MRI
;
magnetic resonance imaging
;
hsp
;
heat shock protein
;
RT-PCR
;
reverse transcriptase-polymerase chain
刊名:Clinical Neurology and Neurosurgery
出版年:2004
1
按检索点细分(5)
作者(3)
按出版年细分(5)
2027年及以后(1)
2016年(1)
2012年(2)
2004年(1)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.